Home » Newsletters » BioWorld Asia

BioWorld Asia

April 21, 1999

View Archived Issues

Elan Inks US$27M Antisense Drug Delivery Deal With Isis

Wellcome Trust, Pharmas Form #28M SNPs Project

Hippocampus Research Offers Alzheimers Clues, And More

European Biotech Robust And Growing, Says Report

GPC Enters Agreements With Evotec, MorphoSys

TAB In Merger Discussions After Searle Deal Crashes

Good News On Relenza Boosts Biota Stock Price

Vectura Raises #1.75M For Lipase Enzyme Work

Cytochroma Investors Give C$2.1M For Enzyme Work

Scotia Drops Cancer Drug After Interim Data Review

Genesis Research Enters Genomics Deal For Trees

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.